HIGHLIGHTS
- who: Masashi Tanaka from the System, United States University of Colorado Anschutz have published the paper: Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1, in the Journal: (JOURNAL)
- what: The authors focused on the glucose metabolism-related profiles, levels of inflammation, serum sTREM2 levels, and MMSE scores (Supplementary Table S1). This study provided the first evidence that higher levels of serum sTREM2 would be a potential novel marker for predicting cognitive impairment in patients with Frontiers in Endocrinology | www . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.